"Arthritis, Rheumatoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Descriptor ID |
D001172
|
| MeSH Number(s) |
C05.550.114.154 C05.799.114 C17.300.775.099 C20.111.199
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Arthritis, Rheumatoid".
Below are MeSH descriptors whose meaning is more specific than "Arthritis, Rheumatoid".
This graph shows the total number of publications written about "Arthritis, Rheumatoid" by people in this website by year, and whether "Arthritis, Rheumatoid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 4 | 0 | 4 |
| 2000 | 1 | 0 | 1 |
| 2001 | 4 | 0 | 4 |
| 2002 | 2 | 0 | 2 |
| 2003 | 2 | 0 | 2 |
| 2004 | 5 | 0 | 5 |
| 2005 | 7 | 0 | 7 |
| 2006 | 13 | 2 | 15 |
| 2007 | 6 | 1 | 7 |
| 2008 | 8 | 1 | 9 |
| 2009 | 10 | 1 | 11 |
| 2010 | 8 | 1 | 9 |
| 2011 | 7 | 5 | 12 |
| 2012 | 8 | 1 | 9 |
| 2013 | 10 | 3 | 13 |
| 2014 | 6 | 2 | 8 |
| 2015 | 13 | 2 | 15 |
| 2016 | 10 | 2 | 12 |
| 2017 | 11 | 7 | 18 |
| 2018 | 10 | 1 | 11 |
| 2019 | 7 | 1 | 8 |
| 2020 | 6 | 1 | 7 |
| 2021 | 10 | 0 | 10 |
| 2022 | 27 | 0 | 27 |
| 2023 | 9 | 0 | 9 |
| 2024 | 4 | 2 | 6 |
| 2025 | 5 | 1 | 6 |
| 2026 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Arthritis, Rheumatoid" by people in Profiles.
-
Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT study. Semin Arthritis Rheum. 2026 Jun; 78:152983.
-
Targeting synovial fibroblast KCa1.1 channels in rheumatoid arthritis. Curr Opin Immunol. 2026 Jun; 100:102747.
-
Interpretable Ensemble Machine Learning Prediction of Nonadherence and the Risk of Nonpersistence of Targeted Disease-Modifying Antirheumatic Agents in Older Adults With Rheumatoid Arthritis. Clin Ther. 2026 Mar; 48(3):214-225.
-
Identifying the strongest novel gene-respiratory disease interactions for rheumatoid arthritis risk. Semin Arthritis Rheum. 2026 Apr; 77:152937.
-
Limosilactobacillus reuteri enables oral-to-systemic absorption of iberiotoxin for treatment of collagen-induced arthritis in rats. Microb Cell Fact. 2025 Aug 02; 24(1):177.
-
Impact of quantitative radiological features of interstitial lung disease on immunomodulatory treatment response in three autoimmune interstitial lung disease cohorts. Thorax. 2025 07 15; 80(8):540-546.
-
Rural-Dwelling Patients With Rheumatoid Arthritis and Risk of Myocardial Infarction Hospitalization: An Observational Study Using the National Inpatient Sample. J Rheumatol. 2025 Jul 01; 52(7):655-661.
-
Rheumatoid arthritis and the risk of 90-day readmission after hospitalization for heart failure. Semin Arthritis Rheum. 2025 Aug; 73:152727.
-
Uncovering specific genetic-respiratory disease endotypes for rheumatoid arthritis risk. Ann Rheum Dis. 2025 Feb; 84(2):221-231.
-
Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study. Ann Rheum Dis. 2025 Feb; 84(2):201-209.